Remedy Entertainment experienced a period of financial contraction during the first half of 2026, characterized by a decline in total revenue and an operating loss of 2.9 million EUR. Revenue for the second quarter fell to 10.2 million EUR, a 40 percent decrease compared to the same period in the previous year. This downturn is primarily attributed to the absence of launch-related accruals that bolstered prior-year figures, compounded by elevated marketing expenditures in anticipation of the upcoming release of Control Resonant. Despite these immediate fiscal pressures, the company maintains its full-year outlook, projecting growth in both revenue and EBITDA as it pivots toward the September 24th launch date.
The company’s balance sheet remains fundamentally stable, supported by an equity ratio of 65.3 percent and total assets valued at 85.1 million EUR. Financial statements indicate a disciplined approach to asset management, with 25.1 million EUR in capitalized development costs as of June 30, 2026, alongside consistent investments in equity funds and convertible bonds. While the net loss for the half-year reached 2.8 million EUR, the organization continues to navigate the inherent volatility of the gaming sector.
Strategic risks persist as the company transitions further into a self-publishing model. Management remains focused on mitigating challenges associated with complex development schedules and the retention of specialized personnel. By prioritizing the successful execution of its upcoming title, the company aims to stabilize its financial trajectory and leverage its existing intellectual property to offset the current period of reduced liquidity and increased operational investment.